How much did Innovaderma achieve in EBIT for the current year?
In the current year, Innovaderma has achieved an EBIT of 108,000 GBP.
Innovaderma EBIT 2024
Innovaderma EBIT
108,000 GBP
Ticker
IDP.L
ISIN
GB00BT9PTW34
WKN
A14TML
In 2024, Innovaderma's EBIT was 108,000 GBP, a -40% increase from the 180,000 GBP EBIT recorded in the previous year.
The Innovaderma EBIT history
| YEAR | EBIT (undefined GBP) |
|---|---|
| 2024e | 0.11 |
| 2023e | 0.18 |
| 2022e | 0.31 |
| 2021 | -1.88 |
| 2020 | -3.85 |
| 2019 | 1.41 |
| 2018 | 0.67 |
| 2017 | 1.03 |
| 2016 | 0.24 |
| 2015 | -0.5 |
Innovaderma Revenue, EBIT, Net Income GB00BT9PTW34 · A14TML
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Innovaderma, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Innovaderma from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Innovaderma’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Innovaderma. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Innovaderma’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Innovaderma’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Innovaderma’s growth potential.
Innovaderma Revenue, EBIT and net profit per share
| Date | Innovaderma Revenue | Innovaderma EBIT | Innovaderma Net Income |
|---|---|---|---|
| 2024e | 11.54 M undefined | 108,000 undefined | 87,260.84 undefined |
| 2023e | 11.77 M undefined | 180,000 undefined | 139,283.96 undefined |
| 2022e | 12.36 M undefined | 309,000 undefined | 228,991.85 undefined |
| 2021 | 10.21 M undefined | -1.88 M undefined | -2.25 M undefined |
| 2020 | 13.21 M undefined | -3.85 M undefined | -4.56 M undefined |
| 2019 | 12.85 M undefined | 1.41 M undefined | 1.01 M undefined |
| 2018 | 10.7 M undefined | 670,000 undefined | 410,000 undefined |
| 2017 | 8.86 M undefined | 1.03 M undefined | 688,950 undefined |
| 2016 | 4.3 M undefined | 241,850 undefined | 177,750 undefined |
| 2015 | 580,560 undefined | -498,905 undefined | -498,900 undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2015 | 580,560 GBP | -498,905 GBP | -498,900 GBP |
| 2016 | 4.3 M GBP | 241,850 GBP | 177,750 GBP |
| 2017 | 8.86 M GBP | 1.03 M GBP | 688,950 GBP |
| 2018 | 10.7 M GBP | 670,000 GBP | 410,000 GBP |
| 2019 | 12.85 M GBP | 1.41 M GBP | 1.01 M GBP |
| 2020 | 13.21 M GBP | -3.85 M GBP | -4.56 M GBP |
| 2021 | 10.21 M GBP | -1.88 M GBP | -2.25 M GBP |
| 2022e | 12.36 M GBP | 309,000 GBP | 228,991.85 GBP |
| 2023e | 11.77 M GBP | 180,000 GBP | 139,283.96 GBP |
| 2024e | 11.54 M GBP | 108,000 GBP | 87,260.84 GBP |
Innovaderma stock margins GB00BT9PTW34 · A14TML
The Innovaderma margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Innovaderma. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Innovaderma.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Innovaderma's sales revenue. A higher gross margin percentage indicates that the Innovaderma retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Innovaderma's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Innovaderma's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Innovaderma's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Innovaderma. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Innovaderma's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Innovaderma Margin History
| Innovaderma Gross margin | Innovaderma Profit margin | Innovaderma EBIT margin | Innovaderma Profit margin |
|---|---|---|---|
| 2024e | 56.71 % | 0.94 % | 0.76 % |
| 2023e | 56.71 % | 1.53 % | 1.18 % |
| 2022e | 56.71 % | 2.5 % | 1.85 % |
| 2021 | 56.71 % | -18.41 % | -22.04 % |
| 2020 | 45.19 % | -29.14 % | -34.52 % |
| 2019 | 62.96 % | 10.97 % | 7.86 % |
| 2018 | 56.92 % | 6.26 % | 3.83 % |
| 2017 | 62.95 % | 11.62 % | 7.78 % |
| 2016 | 57.44 % | 5.62 % | 4.13 % |
| 2015 | 67 % | -85.94 % | -85.93 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2015 | 67 % | -85.94 % | -85.93 % |
| 2016 | 57.44 % | 5.62 % | 4.13 % |
| 2017 | 62.95 % | 11.62 % | 7.78 % |
| 2018 | 56.92 % | 6.26 % | 3.83 % |
| 2019 | 62.96 % | 10.97 % | 7.86 % |
| 2020 | 45.19 % | -29.14 % | -34.52 % |
| 2021 | 56.71 % | -18.41 % | -22.04 % |
| 2022e | 56.71 % | 2.5 % | 1.85 % |
| 2023e | 56.71 % | 1.53 % | 1.18 % |
| 2024e | 56.71 % | 0.94 % | 0.76 % |
Innovaderma Aktienanalyse
What does Innovaderma do?
Innovaderma PLC is a UK-based company that was founded in 2014. It specializes in the development and marketing of natural cosmetic products. The company has quickly made a name for itself in the cosmetics industry through its continuous innovation and market knowledge. Innovaderma's business model is focused on marketing products based on natural ingredients. The company places great value on quality, effectiveness, and high customer orientation. Its goal is to offer high-quality and affordable cosmetic products that are specifically tailored to the needs of its customers. The company operates various divisions to reach its target audiences more effectively and broaden its business. These include: - Skinny Tan: Skinny Tan is a division of the company that specializes in the development and marketing of self-tanning products. The products are based on natural ingredients and provide excellent results without compromising health. - Roots: Roots is a division that specializes in natural hair care products. The products are based on natural ingredients and are free from parabens, sulfates, and other harmful chemicals. - Stevie K: Stevie K is another division that specializes in marketing skincare products for men. The products are based on natural ingredients and provide comprehensive care tailored to the needs of male skin. Innovaderma offers various skincare and hair care products such as shampoos, conditioners, sunscreens, self-tanners, and lotions. The products are known for their high quality and strong focus on customer needs. Innovaderma prides itself on developing its products based on research and development. The company has an experienced research team that continuously works on new formulations to ensure that its products are always one step ahead in the market. The company also has a strong online presence, which allows it to reach a larger target audience and sell its products worldwide. This focus on online sales and e-commerce has helped the company remain successful even amidst the Covid-19 pandemic. Overall, Innovaderma is an emerging force in the cosmetics industry that has quickly gained significance through continued innovation and consistent customer orientation. The company is expected to continue growing and become a prominent player in the natural cosmetics industry. Innovaderma ist eines der beliebtesten Unternehmen auf Eulerpool.com.EBIT Details
Analyzing Innovaderma's EBIT
Innovaderma's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
Year-to-Year Comparison
A yearly comparison of Innovaderma's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Impact on Investments
Innovaderma's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Interpreting EBIT Fluctuations
Fluctuations in Innovaderma’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
Frequently Asked Questions about Innovaderma stock
What is EBIT?
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Innovaderma.
How has the EBIT of Innovaderma developed in recent years?
The EBIT of Innovaderma has increased by -40% decreased compared to the previous year.
What does EBIT mean for investors?
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Why is EBIT an important indicator for investors?
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
Why do EBIT values fluctuate?
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
What role does tax burden play in EBIT?
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
How is EBIT presented in the balance sheet of the company Innovaderma?
The EBIT of Innovaderma is listed in the income statement.
Can EBIT be used as a single indicator for evaluating a company?
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
Why is EBIT not equal to net profit?
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
How much dividend does Innovaderma pay?
Over the past 12 months, Innovaderma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Innovaderma is expected to pay a dividend of 0 GBP.
What is the dividend yield of Innovaderma?
The current dividend yield of Innovaderma is .
When does Innovaderma pay dividends?
Innovaderma pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Innovaderma?
Innovaderma paid dividends every year for the past 0 years.
What is the dividend of Innovaderma?
For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.
In which sector is Innovaderma located?
Innovaderma is assigned to the 'Non-cyclical consumption' sector.
Wann musste ich die Aktien von Innovaderma kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Innovaderma from 9/8/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 9/8/2024.
When did Innovaderma pay the last dividend?
The last dividend was paid out on 9/8/2024.
What was the dividend of Innovaderma in the year 2023?
In the year 2023, Innovaderma distributed 0 GBP as dividends.
In which currency does Innovaderma pay out the dividend?
The dividends of Innovaderma are distributed in GBP.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Innovaderma
Our stock analysis for Innovaderma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Innovaderma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
